What are the side effects and potential hazards of 0.01% Atropine Sulfate Eye Drops (EIKANCE)

0.01% Atropine Sulfate Eye Drops (EIKANCE) is a low-concentration atropine eye drop, mainly used to slow down the progression of myopia in children. Compared with high-concentration atropine, the 0.01% formula significantly reduces the risk of side effects, but attention still needs to be paid to its potential adverse reactions. The most common side effects include short-term eye irritation, mild burning, or watering. These symptoms usually appear within a few minutes of instilling the medication and will gradually ease as you adapt to the medication.

In addition, low concentrations of atropine may still cause mild pupil dilation (mydriasis), resulting in transient glare or blurred vision at night, especially in dark light environments. Although0.01% concentration has minimal effect on regulatory function, it may still cause slight trouble for some children in close reading or learning. During long-term use, a small number of patients may experience dry eyes or occasional mild allergic reactions, such as conjunctival congestion or itching.

From a systemic risk perspective, systemic absorption of low-concentration atropine is extremely low and therefore does not generally cause serious cardiovascular or central nervous system side effects. However, in very rare cases, if children accidentally take eye drops or overdose, they may still experience symptoms such as rapid heartbeat, dry mouth, or mild dizziness. Overall, the safety of 0.01% atropine sulfate eye drops has been widely recognized in global clinical studies, but it is still necessary to follow the guidance of a doctor during use to avoid excessive dosage and improper operation.

In long-term management, it is very important to regularly review intraocular pressure, corneal health and vision changes to ensure that the medication is safe and effective. When supervising the medication, parents should pay attention to observe whether their children have eye discomfort or abnormal vision, and communicate with the ophthalmologist in a timely manner. Through standardized use and continuous monitoring,0.01% Atropine Sulfate Eye Drops can provide effective myopia control support with a low risk of side effects.

Reference materials:https://www.eikance.com.au/